High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy
Abstract Adenoviruses are very efficient vectors for delivering therapeutic genes in preclinical and clinical trials. However, randomized controlled human trials have often been lacking clear clinically relevant results. We hypothesized that high lipid levels and specific lipoproteins could signific...
Guardado en:
Autores principales: | A. M. Kivelä, J. Huusko, E. Gurzeler, A. Laine, M. H. Dijkstra, G. Dragneva, C. B. F. Andersen, S. K. Moestrup, S. Ylä-Herttuala |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/13eec640ea744d0e8b268a995fb998d0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice.
por: Erika Gurzeler, et al.
Publicado: (2021) -
SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice
por: Erika Gurzeler, et al.
Publicado: (2021) -
A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition.
por: Neda Bagheri, et al.
Publicado: (2011) -
Epigenetic upregulation of endogenous VEGF-A reduces myocardial infarct size in mice.
por: Mikko P Turunen, et al.
Publicado: (2014) -
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses.
por: Anna Kanerva, et al.
Publicado: (2008)